The good msb news this morning highlights that if new stem cell based treatments come on board that millions of doses could be required. How does this happen ??? Cymerus is the answer. Has to be a flow on here. Or there would be if this company’s technology and potential was being properly sold and marketed. Anytime now would be good.
Cynata has manufacturing solution for new covd treatments
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.020(8.16%) |
Mkt cap ! $40.68M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 22.5¢ | $32.92K | 143.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21235 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 17528 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |